Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data?
作者： L. Parker Gregg , S. Susan Hedayati
DOI: 10.1053/J.AJKD.2017.12.007
关键词: Observational study 、 Glycemic 、 Kidney disease 、 Albuminuria 、 Aspirin 、 Medicine 、 Dialysis 、 Weight loss 、 Internal medicine 、 Population
摘要: … The risks of aspirin may equal the benefits in NDD-CKD … Heart Attack Trial (ALLHAT) stratified by eGFR showed no … to placebo in more than 9,000 participants with CKD, ∼30% of whom …
ajkd.org
elsevier.com参考文章(107)
Carmine Zoccali, Francesca Mallamaci, Giovanni Tripepi, Frank A Benedetto, Emilio Cottini, Giuseppe Giacone, Lorenzo Malatino, CREED investigators, Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients Journal of Hypertension. ,vol. 17, pp. 1751- 1758 ,(1999) , 10.1097/00004872-199917120-00013
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 358, pp. 2560- 2572 ,(2008) , 10.1056/NEJMOA0802987
Meg J. Jardine, Toshiharu Ninomiya, Vlado Perkovic, Alan Cass, Fiona Turnbull, Martin P. Gallagher, Sophia Zoungas, Hiddo J. Lambers Heerspink, John Chalmers, Alberto Zanchetti, Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease: A Post-Hoc Subgroup Analysis of a Randomized Controlled Trial Journal of the American College of Cardiology. ,vol. 56, pp. 956- 965 ,(2010) , 10.1016/J.JACC.2010.02.068
Gennaro Cice, Luigi Ferrara, Antonello D’Andrea, Salvatore D’Isa, Attilio Di Benedetto, Antonio Cittadini, Pina Elvira Russo, Paolo Golino, Raffaele Calabrò, Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: A prospective, placebo-controlled trial Journal of the American College of Cardiology. ,vol. 41, pp. 1438- 1444 ,(2003) , 10.1016/S0735-1097(03)00241-9
ChongTing Lin, Qing Zhang, HuiFang Zhang, AiXia Lin, Long-Term Effects of Low-Dose Spironolactone on Chronic Dialysis Patients: A Randomized Placebo-Controlled Study. Journal of Clinical Hypertension. ,vol. 18, pp. 121- 128 ,(2016) , 10.1111/JCH.12628
WORKGROUP KD, None, K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. American Journal of Kidney Diseases. ,vol. 45, ,(2005)
Kamyar Kalantar-Zadeh, Kevin C Abbott, Abdulla K Salahudeen, Ryan D Kilpatrick, Tamara B Horwich, Survival advantages of obesity in dialysis patients The American Journal of Clinical Nutrition. ,vol. 81, pp. 543- 554 ,(2005) , 10.1093/AJCN/81.3.543
Marinella Ruospo, Valeria M Saglimbene, Suetonia C Palmer, Salvatore De Cosmo, Antonio Pacilli, Olga Lamacchia, Mauro Cignarelli, Paola Fioretto, Mariacristina Vecchio, Jonathan C Craig, Giovanni FM Strippoli, Glucose targets for preventing diabetic kidney disease and its progression Cochrane Database of Systematic Reviews. ,vol. 2017, pp. 0- 0 ,(2017) , 10.1002/14651858.CD010137.PUB2
Robert H. Eckel, John M. Jakicic, Jamy D. Ard, Janet M. de Jesus, Nancy Houston Miller, Van S. Hubbard, I-Min Lee, Alice H. Lichtenstein, Catherine M. Loria, Barbara E. Millen, Cathy A. Nonas, Frank M. Sacks, Sidney C. Smith, Laura P. Svetkey, Thomas A. Wadden, Susan Z. Yanovski, 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk Circulation. ,vol. 129, pp. 2960- 2984 ,(2014) , 10.1161/01.CIR.0000437740.48606.D1